![]() | ![]() |
Formats:
|
||||
Reduction in duration of common colds by zinc gluconate lozenges in a double-blind study. This article has been cited by other articles in PMC.Abstract As a possible treatment for common colds, we tested zinc gluconate lozenges in a double-blind, placebo-controlled, clinical trial. One 23-mg zinc lozenge or matched placebo was dissolved in the mouth every 2 wakeful h after an initial double dose. After 7 days, 86% of 37 zinc-treated subjects were asymptomatic, compared with only 46% of 28 placebo-treated subjects (P = 0.0005). Side effects or complaints were usually minor and consisted mainly of objectionable taste and mouth irritation. Zinc lozenges shortened the average duration of common colds by about 7 days. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (894K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. Selected References These references are in PubMed. This may not be the complete list of references from this article.
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||